Microsoft Word[removed]FINAL Questions[removed]doc

First Page		Document Content
Antiprotozoal agents Antifungals Miltefosine Leishmaniasis Cutaneous leishmaniasis Visceral leishmaniasis Leishmania Food and Drug Administration Labeling theory Medicine Microbiology Biology		Microsoft Word[removed]FINAL Questions[removed]doc Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 19,14 KB Share Document on Facebook

	Leishmaniasis 2018 Registration Form I International Symposium on Leishmaniasis 29th - 31st October 2018 DocID: 1uVf8 - View Document
	Mezinárodní projekt s českou účastí http://vl-ethiopia.huji.ac.il/index.htm About THE PROJECT Visceral leishmaniasis (VL) known as Kala-Azar is a very serious disease caused by Leishmania donovani parasites. An est DocID: 1tYgX - View Document
	A single compound could treat three parasitic diseases DocID: 1rkR2 - View Document
	Fundación MEDINA DocID: 1qTxX - View Document
	PUBLICise HEALTH Public Health Telegram on Vector-borne Diseases PhBD 7diseases Issue No. 5 – PhBD DocID: 1qCPB - View Document